The latest biotech news

News and Trends 15 Oct 2014

New Peptide Technology Against Cancer bags 25 Million Euros

Bicycle Therapeutics, a next generation biotherapeutics UK-based company developing first-in-class bicyclic peptides, announced that it had secured an equity financing of €25 million for the clinical development of therapeutic bicycle drug candidates in oncology. Bicycle has used its proprietary bicyclic peptide technology that enables to discover a new class of drug candidates, which have similar selectivity […]

October 15, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 15 Oct 2014

Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer

Rigontec GmbH, a German privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announced the first closing of its Series A financing round, raising €9.45 million. Rigontec was launched in January 2014 as a spin-out of the Institute for Clinical Chemistry and Clinical Pharmacology at the University of Bonn, Germany. The Company’s […]

October 15, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 13 Oct 2014

Future Organ-on-a-chip Global Leader MIMETAS raised 4 Million euros

Dutch biotech MIMETAS B.V. announces that it has raised 4 Million euros ($5.2M) to fund its expansion as a global leader in organ-on-a-chip technology. Venture capital investors Zeeuws Investerings Fonds (ZIF) and Participatiemaatschapij Oost Nederland (PPM Oost) have joined forces with national and regional partners, to fund development and sales of MIMETAS’ unique 3D disease- […]

October 13, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 11 Oct 2014

ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development

ARTES Biotechnology, InstrAction and Q-Biologicals establish a three-party consortium for vaccine developments for veterinary applications. Nowadays virus-like particles (VLPs) have become a widely used vehicle for the development of vaccines used in humans. Without being infectious, the particles are used to transport foreign antigens in an ideal way to the immune system. For veterinary applications, the applied VLP production […]

October 11, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 10 Oct 2014

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

American Biotech company Gilead is selling its new drug Sovaldi since 2013, which brings significant breakthrough in Hepatitis C treatment. The high cost of the drug, up to €100 000, is a challenge for european Public Health system which tries to lower its overall cost for their public health system. Hepatitis C is an infectious disease […]

October 10, 2014 - 3 minutesmins - By Philip Hemme

News and Trends 8 Oct 2014

Once a Week Insulin Shot : Novo Nordisk’s new Idea

Denmark’s Novo Nordisk, the world’s largest insulin seller, is betting on a new way to stay ahead in the $40 billion-plus diabetes market by trying to develop the world’s first once-weekly insulin injection. Almost 592 million people are expected to live with diabetes by 2035, up 55 percent from last year’s level, according to the International Diabetes […]

October 8, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 8 Oct 2014

Baden-Württemberg Healthcare Industry Forum 2014, discover one of the largest cluster in Germany

Last September 24th was held the Baden-Württemberg Healthcare Industry Forum 2014, organized by BIOPRO the biotech cluster of this German region. It was an opportunity to review the bilan of the cluster and to learn interesting facts. BIOPRO has listed 159 biotech companies in the Baden-Württemberg area, representing a workforce of more than 22,000 employees and a turnover […]

October 8, 2014 - 6 minutesmins - By Joachim Eeckhout

News and Trends 4 Oct 2014

A Hydrogel to treat Advanced Heart Failure in Europe

LoneStar Heart, Inc. announced that it received the CE Mark (European Conformity) for its Algisyl-LVR® hydrogel implant,a product for the treatment of advanced heart failure (HF). The CE Mark indicates a product’s compliance with European Union legislation and that it can be sold throughout the European Economic Area. Classified in Europe and in the U.S. as a medical device, Algisyl-LVR is […]

October 4, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 3 Oct 2014

A new way to develop therapeutic monoclonal antibodies against Cancer

Up to now, a vast majority of antibodies targets proteins. Why not targeting something else? ImmuSmol, a start-up based in Bordeaux South of France is developing monoclonal antibodies against small molecules involved in tumor immune escape. This French start-up has just raised €500k to complete its preclinical proof-of-concept. Bordeaux is one of the biggest wine […]

October 3, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 2 Oct 2014

BioNTech and Ganymed Pharmaceuticals Open One of the Largest Research Facilities in Germany

BioNTech AG and Ganymed Pharmaceuticals AG, two leading German biotechnology companies, announced today the joint- opening of a new headquarters and research facility of approximatively 10,000 square-meters. The new facility brings together 300 employees and is located close to academic institutions (Johannes-Gutenberg University), hospitals (University Medical Center) and cancer research institutions such as the leading translational oncology […]

October 2, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 30 Sep 2014

New Collaboration for New Cancer Therapies

Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered into a collaboration to establish a joint lab in Cambridge, UK, with Cancer Research Technology, the commercial arm of Cancer Research UK. The new laboratory will be the first partnership of its kind of both organizations, and will focus on […]

September 30, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 29 Sep 2014

How to Save Thousands of Lives Thanks to Tuberculosis Test Fitting in your Pocket?

The EU-funded POCKET project is developing a low-cost urine test that can quickly detect tuberculosis (TB), a preventable disease that kills nearly 2 million people every year. Started in November 2013, the initiative already started and develops a low-cost urine test that will make TB detection accessible to all. Right now, researchers working on POCKET […]

September 29, 2014 - 2 minutesmins - By Julie Lellouche

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

New Peptide Technology Against Cancer bags 25 Million Euros

Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer

Future Organ-on-a-chip Global Leader MIMETAS raised 4 Million euros

ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

Once a Week Insulin Shot : Novo Nordisk’s new Idea

Baden-Württemberg Healthcare Industry Forum 2014, discover one of the largest cluster in Germany

A Hydrogel to treat Advanced Heart Failure in Europe

A new way to develop therapeutic monoclonal antibodies against Cancer

BioNTech and Ganymed Pharmaceuticals Open One of the Largest Research Facilities in Germany

New Collaboration for New Cancer Therapies

How to Save Thousands of Lives Thanks to Tuberculosis Test Fitting in your Pocket?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!